Mitochondrial Dynamics in Non-Small Cell Lung Cancer
Cancers · 12.08.2024 · 16 (16) · 2823
DOI: 10.3390/cancers16162823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 12.08.2024. Verfasst von Agata Dutkowska und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Oncological Pulmonology, Medical University of Lodz, 90-647 Lodz, Poland. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In lung cancer patients, two complementary abnormalities were found that can cause disruption of the mitochondrial network: increased fusion and impaired fission, manifested by reduced levels of FIS1, a mitochondrial division regulator, and increased expression of MFN1, a mitochondrial fusion mediator. Immunoexpression studies of MFN1 and FIS1 proteins were performed in serum samples obtained from 47 patients with non-small cell lung cancer (NSCLC) and 21 controls. In the NSCLC patients, the immunoexpression of the MFN1 protein was significantly higher, and the FIS1 protein level was significantly lower than in the control group (p < 0.01; p < 0.001; UMW test). Patients with early, operable lung cancer had significantly lower levels of MFN1 immunoexpression compared to patients with advanced, metastatic lung cancer (p < 0.05; UMW test). This suggests that early stages of the disease are characterized by greater fragmentation of damaged mitochondria and apoptosis. In contrast, lower FIS1 protein levels were associated with a worse prognosis. Increased mitochondrial fusion in the blood of lung cancer patients may suggest an increase in protective and repair mechanisms. This opens up questions about why these mechanisms fail in the context of existing advanced cancer disease and is a starting point for further research into why protective mechanisms fail in lung cancer patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General and Oncological Pulmonology, Medical University of Lodz, 90-647 Lodz, Poland.
- Department of Biomedicine and Genetics, Medical University of Lodz, 90-647 Lodz, Poland.
- Department of Thoracic, General and Oncological Surgery, Medical University of Lodz, 90-647 Lodz, Poland.
ORCID-Profile: Karolina H Czarnecka-Chrebelska, Maria Możdżan, Edward Zheng, Ewa Brzeziańska-Lasota, Michał Poznański
Zitieren
APA
Dutkowska, A., Domańska-Senderowska, D., Czarnecka-Chrebelska, K. H., Pikus, E., Zielińska, A., Biskup, L., Kołodziejska, A., Madura, P., Możdżan, M., Załuska, U., Zheng, E., Adamczyk, E., Kędzia, K., Wcisło, S., Wawrzycki, M., Brzeziańska-Lasota, E., Jabłoński, S., Antczak, A., & Poznański, M. (2024). Mitochondrial Dynamics in Non-Small Cell Lung Cancer. Cancers, 16(16), 2823. https://doi.org/10.3390/cancers16162823
Vancouver
Dutkowska A, Domańska-Senderowska D, Czarnecka-Chrebelska KH, Pikus E, Zielińska A, Biskup L, et al. Mitochondrial Dynamics in Non-Small Cell Lung Cancer. Cancers. 2024;16(16):2823. doi:10.3390/cancers16162823
BibTeX
@article{Dutkowska2024,
author = {Dutkowska, Agata and Domańska-Senderowska, Daria and Czarnecka-Chrebelska, Karolina H and Pikus, Ewa and Zielińska, Aleksandra and Biskup, Laura and Kołodziejska, Agata and Madura, Paulina and Możdżan, Maria and Załuska, Urszula and Zheng, Edward and Adamczyk, Eliza and Kędzia, Konrad and Wcisło, Szymon and Wawrzycki, Marcin and Brzeziańska-Lasota, Ewa and Jabłoński, Sławomir and Antczak, Adam and Poznański, Michał},
title = {Mitochondrial Dynamics in Non-Small Cell Lung Cancer},
journal = {Cancers},
year = {2024},
volume = {16},
number = {16},
pages = {2823},
doi = {10.3390/cancers16162823}
}
EUVIMED